China Life Insurance (02628) plans to establish partnerships with China Life Insurance Wuxi Fund, China Life Insurance Chengda and other investors to focus on investing in the two major fields of technological innovation, artificial intelligence and semiconductors

According to the Zhitong Finance App, China Life Insurance (02628) announced that the company, China Life Insurance Wuxi Fund (an indirect subsidiary of the group company) and other investors (all parties are limited partners) intend to enter into a partnership agreement with China Life Insurance Chengda (as general partners) to establish a partnership. The total amount of capital to be pledged by all partners of the partnership shall not exceed RMB 6 billion, of which the Company intends to pledge no more than RMB 4.5 billion. China Life Insurance Co., Ltd. will act as the manager of the partnership. It is anticipated that the Company will enter into partnership agreements and subsidiary agreements with relevant parties before December 31, 2026.

The partnership will closely follow the policy direction of self-reliance and self-improvement in technology and industrial autonomy and control, focus on investing in the two major fields of scientific and technological innovation of artificial intelligence and semiconductors, and focus on the equity of high-quality unlisted companies with core technical barriers in the industrial chain, broad domestic replacement space, and outstanding long-term growth certainty.

The partnership will mainly invest in unlisted shares of high-quality enterprises in the field of scientific and technological innovation established and operated in China. The partnership is expected to invest in the fields of artificial intelligence and semiconductors, in close line with the country's strategic direction. Artificial intelligence is a key field of current global technological competition, while semiconductors are the cornerstone of autonomous and controllable industrial chains. Both directions have long-term determined growth space and policy support. Investment partnerships are not only an important step for the company to implement the “15th Five-Year Plan” plan, support the development of emerging pillar industries, and cultivate new quality productivity, but also an important gripper for optimizing the company's asset allocation and seizing the long-term growth dividends of hard technology.

China Life Insurance, the manager of the partnership, has rich investment experience in the field of scientific and technological innovation. It has achieved good historical results in science and technology innovation projects in the Big Health series of funds it manages, and the manager's core management team is stable and the investment team has diverse professional backgrounds, which is conducive to the long-term effective promotion of partnership strategies. At the same time, benefiting from the “China Life Insurance” brand and collaborative advantages, managers can use resources and connections in financial institutions and related industries to obtain advantages in project exploration and service to invested enterprises. These investment experience and resource advantages match the partnership strategy and help the partnership to obtain good returns, thereby optimizing the company's asset allocation and improving the company's profit level.